These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 33892797)
1. Sensitive detection of colorectal cancer in peripheral blood by a novel methylation assay. Zhang Y; Wu Q; Xu L; Wang H; Liu X; Li S; Hu T; Liu Y; Peng Q; Chen Z; Wu X; Fan JB Clin Epigenetics; 2021 Apr; 13(1):90. PubMed ID: 33892797 [TBL] [Abstract][Full Text] [Related]
2. Identifying potential DNA methylation markers in early-stage colorectal Cancer. Zhang X; Wan S; Yu Y; Ruan W; Wang H; Xu L; Wang C; Chen S; Cao T; Peng Q; Li S; Hu T; Jiang Z; Chen Z; Fan JB Genomics; 2020 Sep; 112(5):3365-3373. PubMed ID: 32531444 [TBL] [Abstract][Full Text] [Related]
3. Novel DNA methylation biomarkers show high sensitivity and specificity for blood-based detection of colorectal cancer-a clinical biomarker discovery and validation study. Jensen SØ; Øgaard N; Ørntoft MW; Rasmussen MH; Bramsen JB; Kristensen H; Mouritzen P; Madsen MR; Madsen AH; Sunesen KG; Iversen LH; Laurberg S; Christensen IJ; Nielsen HJ; Andersen CL Clin Epigenetics; 2019 Nov; 11(1):158. PubMed ID: 31727158 [TBL] [Abstract][Full Text] [Related]
4. Combined detection of plasma GATA5 and SFRP2 methylation is a valid noninvasive biomarker for colorectal cancer and adenomas. Zhang X; Song YF; Lu HN; Wang DP; Zhang XS; Huang SL; Sun BL; Huang ZG World J Gastroenterol; 2015 Mar; 21(9):2629-37. PubMed ID: 25759530 [TBL] [Abstract][Full Text] [Related]
5. Combined SEPT9 and BMP3 methylation in plasma for colorectal cancer early detection and screening in a Brazilian population. Lima AB; Dos Reis MB; Matsushita M; Dos Reis MT; de Oliveira MA; Reis RM; Guimarães DP Cancer Med; 2023 Aug; 12(15):15854-15867. PubMed ID: 37338022 [TBL] [Abstract][Full Text] [Related]
6. A novel method for early detection of colorectal cancer based on detection of methylation of two fragments of syndecan-2 (SDC2) in stool DNA. Ma L; Qin G; Gai F; Jiang Y; Huang Z; Yang H; Yao S; Du S; Cao Y BMC Gastroenterol; 2022 Apr; 22(1):191. PubMed ID: 35436855 [TBL] [Abstract][Full Text] [Related]
7. Detection of promoter hypermethylation of Wnt antagonist genes in fecal samples for diagnosis of early colorectal cancer. Zhang H; Zhu YQ; Wu YQ; Zhang P; Qi J World J Gastroenterol; 2014 May; 20(20):6329-35. PubMed ID: 24876755 [TBL] [Abstract][Full Text] [Related]
8. A new approach to epigenome-wide discovery of non-invasive methylation biomarkers for colorectal cancer screening in circulating cell-free DNA using pooled samples. Gallardo-Gómez M; Moran S; Páez de la Cadena M; Martínez-Zorzano VS; Rodríguez-Berrocal FJ; Rodríguez-Girondo M; Esteller M; Cubiella J; Bujanda L; Castells A; Balaguer F; Jover R; De Chiara L Clin Epigenetics; 2018; 10():53. PubMed ID: 29686738 [TBL] [Abstract][Full Text] [Related]
9. Multiplex methylated DNA testing in plasma with high sensitivity and specificity for colorectal cancer screening. Zhao G; Li H; Yang Z; Wang Z; Xu M; Xiong S; Li S; Wu X; Liu X; Wang Z; Zhu Y; Ma Y; Fei S; Zheng M Cancer Med; 2019 Sep; 8(12):5619-5628. PubMed ID: 31407497 [TBL] [Abstract][Full Text] [Related]
10. Feasibility of quantifying Oh TJ; Oh HI; Seo YY; Jeong D; Kim C; Kang HW; Han YD; Chung HC; Kim NK; An S Clin Epigenetics; 2017; 9():126. PubMed ID: 29225717 [TBL] [Abstract][Full Text] [Related]
11. Combined Plasma MicroRNA and Fecal Occult Blood Tests in Early Detection of Colorectal Cancer. Luo X; Wu Y; Ji M; Zhang S Clin Lab; 2019 May; 65(5):. PubMed ID: 31115212 [TBL] [Abstract][Full Text] [Related]
12. A systematic review and quantitative assessment of methylation biomarkers in fecal DNA and colorectal cancer and its precursor, colorectal adenoma. Liu R; Su X; Long Y; Zhou D; Zhang X; Ye Z; Ma J; Tang T; Wang F; He C Mutat Res Rev Mutat Res; 2019; 779():45-57. PubMed ID: 31097151 [TBL] [Abstract][Full Text] [Related]
13. Detection of colorectal neoplasm using promoter methylation of ITGA4, SFRP2, and p16 in stool samples: a preliminary report in Korean patients. Chang E; Park DI; Kim YJ; Kim BK; Park JH; Kim HJ; Cho YK; Sohn CI; Jeon WK; Kim BI; Kim HD; Kim DH; Kim YH Hepatogastroenterology; 2010; 57(101):720-7. PubMed ID: 21033217 [TBL] [Abstract][Full Text] [Related]
14. Epigenome-wide discovery and evaluation of leukocyte DNA methylation markers for the detection of colorectal cancer in a screening setting. Heiss JA; Brenner H Clin Epigenetics; 2017; 9():24. PubMed ID: 28270869 [TBL] [Abstract][Full Text] [Related]
15. A novel cell-free DNA methylation-based model improves the early detection of colorectal cancer. Wu X; Zhang Y; Hu T; He X; Zou Y; Deng Q; Ke J; Lian L; He X; Zhao D; Cai X; Chen Z; Wu X; Fan JB; Gao F; Lan P Mol Oncol; 2021 Oct; 15(10):2702-2714. PubMed ID: 33694305 [TBL] [Abstract][Full Text] [Related]
16. Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. Rademakers G; Massen M; Koch A; Draht MX; Buekers N; Wouters KAD; Vaes N; De Meyer T; Carvalho B; Meijer GA; Herman JG; Smits KM; van Engeland M; Melotte V Clin Epigenetics; 2021 Apr; 13(1):80. PubMed ID: 33858496 [TBL] [Abstract][Full Text] [Related]
17. Performance of a second-generation methylated SEPT9 test in detecting colorectal neoplasm. Jin P; Kang Q; Wang X; Yang L; Yu Y; Li N; He YQ; Han X; Hang J; Zhang J; Song L; Han Y; Sheng JQ J Gastroenterol Hepatol; 2015 May; 30(5):830-3. PubMed ID: 25471329 [TBL] [Abstract][Full Text] [Related]
18. Cao Y; Zhao G; Yuan M; Liu X; Ma Y; Cao Y; Miao B; Zhao S; Li D; Xiong S; Zheng M; Fei S Front Oncol; 2020; 10():621295. PubMed ID: 33585248 [TBL] [Abstract][Full Text] [Related]
19. Discovery and validation of methylation signatures in blood-based circulating tumor cell-free DNA in early detection of colorectal carcinoma: a case-control study. Sui J; Wu X; Wang C; Wang G; Li C; Zhao J; Zhang Y; Xiang J; Xu Y; Nian W; Cao F; Yu G; Lou Z; Hao L; Liu L; Li B; Zhang Z; Cai S; Liu H; Lan P; Zhang W Clin Epigenetics; 2021 Feb; 13(1):26. PubMed ID: 33536049 [TBL] [Abstract][Full Text] [Related]
20. Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomas. Gallardo-Gómez M; Rodríguez-Girondo M; Planell N; Moran S; Bujanda L; Etxart A; Castells A; Balaguer F; Jover R; Esteller M; Cubiella J; Gómez-Cabrero D; De Chiara L Clin Epigenetics; 2023 Oct; 15(1):157. PubMed ID: 37794510 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]